9999999997-14-014057.txt : 20141002
9999999997-14-014057.hdr.sgml : 20141002
20141002144515
ACCESSION NUMBER: 9999999997-14-014057
CONFORMED SUBMISSION TYPE: CT ORDER
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20141002
DATE AS OF CHANGE: 20141002
20141002
20141002
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: PDL BIOPHARMA, INC.
CENTRAL INDEX KEY: 0000882104
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943023969
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: CT ORDER
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19756
FILM NUMBER: 141135934
BUSINESS ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
BUSINESS PHONE: 775-832-8500
MAIL ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE
DATE OF NAME CHANGE: 19930328
CT ORDER
1
filename1.pdf
begin 644 filename1.pdf
M)5!$1BTQ+C4-)>+CS],-"C0R(#`@;V)J#3P\+TQI;F5AF4@-34O5'EP92]84F5F+U=;,2`R(#%=/CYS=')E86T-"FC>8F)D$&!@
M8F#R`A(,4X`$XPT@P1(()-BV`8G/RQF8&!EV@F09&-&)_XRS_@`$&`#6)0?D
M#0IE;F1S=')E86T-96YD;V)J#7-T87)T>')E9@T*,`T*)25%3T8-"B`@("`@
M("`@#0HU-"`P(&]B:@T\/"]#(#8Y+T9I;'1E8F!@8&%@8(IF``(>1@94`.*S
M,'`T((NQ0#$#PPT&;@;.9^]9%D"5RLI#:*849,7ZVR"BC/(``08``1L&%PT*
M96YD7!E+U!A9V4^/@UE;F1O8FH--#4@,"!O8FH-/#PO1FEL=&5R+T9L871E
M1&5C;V1E+T9I;ORH9,4*X
M(3/X].N$\T!2VA1C80V^5*DN%MY]G'O7.MFK@QN)B\IH4]KR0`Q)NF3E"OMG
M;`\Y_=KV:^\/.8ZHC'Q(JF\`^E-%AU/#4?7-TQ,.?0-RYSN"JAA=(P2WI
M(3TNX4MWP2&K)PC$($+UG10C`AY`UG,P3B>D]YG!AIL#FTK1+WU3C6N"&IAU
M]B[?Z`$Z.J0QP@GB2$3`C40(20=F',CZ$1D#QB>?+[IO*J(\IKV6GA5?:D\)ZKN>)_UES%
M!OD$10$?MZ.KG*BS)3?,IJOA`;.;"KYWI^)[X.\%
M?$&:^[Q8<562!C%!I>U5,:AC)$#QO1+^'A_ZI3A><4_&BJMZTXL+N47`Y?R6X7A%>"6YJS]#;B(%)8.M)&`-O.Z6W2LM]O>6O]59%1S0&
M;-3_?6.$FCV.Y6/[D^/UO>P=DE0`?/N/Y?88O-P>AY/;WP(,`+D'?&0-"F5N
M9'-T7W'`OI"#Q8C4>U$4
M<.QD2]%Z7:("`]QA\,NR>/!;$WOM_OWNCA(IV8[5`5L`,Q)YY-T]]]P==55>
M7'Z`UZ\OWP]NAQ#"FS=7PP%<7`[N0Y@]XP0\S]87EV49@H;RX4(;"$*IPC""
MXA/